Skip to main content
Log in

Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The ability of technetium-99m-labelled polyclonal human immunoglobulin G (99mTc-IgG) scintigraphy to predict joint destruction in patients with rheumatoid arthritis (RA) was investigated in this study. The progression of radiographically determined joint destruction in wrists, hands and feet was compared with the results of physical and laboratory examination, as well as 99mTc-IgG scintigraphy, measured at the beginning of a year-long study on 30 patients with RA of recent onset. The sensitivity of joint swelling in predicting the progression of radiographically determined joint destruction ranged between 57% and 74%. The sensitivity of 99mTc-IgG scintigraphy ranged between 71% and 100%. The specificity and positive predictive value both of joint swelling and 99mTc-IgG scintigraphy were low. Multiple regression analysis showed that for the total joint score, and for the metacarpophalangeal and forefeet joints, progression of radiographically determined joint destruction was primarily predicted by 99mTc-IgG scintigraphy. Joint swelling, ESR and IgM rheumatoid factor did not contribute to this prediction. We concluded that 99mTc-IgG scintigraphy is superior to conventional clinical and laboratory measurements in RA with respect to prediction of joint destruction.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Heijde van der DMFM, Riel van PLCM, Leeuwen van MA, Hofvan't MA, Rijswijk van MH, Putte van de LBA (1992) Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients. Br J Rheumatol 31:519–525

    Google Scholar 

  2. Heyde van der DMFM, Hof van't MA, Riel van PLCM, Theunisse LAM, Lubberts EW, van Leeuwen MA, van Rijswijk MH, van de Putte LBA (1990) Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 49:916–920

    Google Scholar 

  3. Bull BS, Westengard JC, Furr M, Bacon PA, Meyer PJ, Stuart J (1989) Efficacy of tests used to monitor rheumatoid arthritis. Lancet II:965–967

    Google Scholar 

  4. Breedveld FC, Kroonenburgh van MJPG, Camps JAJ, Feitsma HIJ, Markusse HM, Pauwels EKJ (1989) Imaging of inflammatory arthritis with technetium-99m labelled IgG. J Nucl Med 30:2017–2021

    Google Scholar 

  5. Lubbe van der PAHM, Arndt JW, Calame W, Ferreira TC, Pauwels EKJ, Breedveld FC (1991) Measurement of synovial inflammation in rheumatoid arthritis with technetium-99m labelled human polyclonal immunoglobulin G. Eur J Nucl Med 18:119–123

    Google Scholar 

  6. Berná L, Torres G, Diez C, Estorch M, Martinez-Duncher D, Carrio I (1992) Technetium-99m human polyclonal immunoglobulin G studies and conventional bone scans to detect active joint inflammation in chronic rheumatoid arthritis. Eur J Nucl Med 19:173–176

    Google Scholar 

  7. Bois de MHW, Arndt JW, Velde van der EA, Lubbe van der PAHM, Westedt ML, Pauwels EKJ, Breedveld FC (1992) 99mTc human immunoglobulin scintigraphy — a reliable method to detect joint activity in rheumatoid arthritis. J Rheumatol 13:1371–1376

    Google Scholar 

  8. Liberatore M, Clemente M, Iurilli AP, Zorzin L, Marini M, Di Rocco E, Cotella AC (1992) Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloids. Eur J Nucl Med 19:853–857

    Google Scholar 

  9. Pons F, Moyá F, Herranz R, Solá M, Del Olmo JA, Piera C, Muñoz-Gomez J, Setoain J (1993) Detection and quantitative analysis of joint activity inflammation with 99Tcm-polyclonal human immunoglobulin G. Nucl Med Commun 14:225–231

    Google Scholar 

  10. Bois de MHW, Arndt JW, Velde van der EA, Pauwels EKJ, Breedveld FC (1994) Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to late phase scintigraphy with 99mTc-labelled disphosphonate. Br J Rheumatol 33:67–73

    Google Scholar 

  11. Bois de MHW, Arndt JW, Tak PP, Kluin PM, van der Velde EA, Pauwels EKJ, Breedveld FC (1993) 99Tcm-labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis. Nucl Med Commun 14:883–887

    Google Scholar 

  12. Bois de MHW, Westedt M-L, Arndt JW, Wiarda KS, Velde van der EA, Pauwels EKJ, Breedveld FC (1995) Technetium-99m labelled polyclonal human immunoglobulin G scintigraphy before and 26 weeks after initiation of parenteral gold treatment in patients with rheumatoid arthritis. J Rheumatol 22:1461–1465

    Google Scholar 

  13. Bois de HW, Tak PP, Arndt JW, Kluin PM, Pauwels EKJ, Breedveld FC (1995) Joint scintigraphy for quantification of synovitis with 99mTc-labelled human immunoglobulin G compared to histological examination. Clin Exp Rheumatol 13:155–159

    Google Scholar 

  14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classitication of rheumatoid arthritis. Arthritis Rheum 31:315–324

    Google Scholar 

  15. Kellgren JH (ed) (1963) The epidemiology of chronic rheumatism. Atlas of standard radiographs of arthritis, vol 2. Blakwell, Oxford

    Google Scholar 

  16. Brook A, Corbett M (1977) Radiographic changes in early rheumatoid disease. Ann Rheum Dis 36:71–73

    Google Scholar 

  17. Fuch HA, Kaye JJ, Callahan LF, Nance EP, Pincus T (1989) Eveidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 16:585–591

    Google Scholar 

  18. Salaffi F, Ferraccioli GF (1989) Progress of the anatomical damage in rheumatoid hands. Radiography of the natural course of the disease or the course during treatment? Scand J Rheumatol 18:119–120

    Google Scholar 

  19. Pincus T (1994) Rheumatoid arthritis: a medical emergency? Scand J Rheumatol 23 [Suppl 100]:21–30

    Google Scholar 

  20. Zeben D van, Hazes JMW, Zwinderman AH, Vandenbroucke JP, Breedveld FC (1993) Factors predicting outcome of rheumatoid arthritis: results of a follow-up study. J Rheumatol 20: 1288–1296

    Google Scholar 

  21. Möttönen TT, Hannonen P, Rekonen A, Oka M (1986) Joint scintigraphy and erosions. Ann Rheum Dis 45:966–968

    Google Scholar 

  22. Möttönen TT, Hannonen P, Toivanen J, Rekonen A, Oka M (1988) Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis. Ann Rheum Dis 47:183–189

    Google Scholar 

  23. Pitt P, Berry H, Clarke M, Foley H, Barratt J, Parsons V (1986) Metabolic activity of erosions in rheumatoid arthritis. Ann Rheum Dis 45:235–238

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Bois, M.H.W., Westedt, M.L., Arndt, J.W. et al. Value of 99mTc-IgG scintigraphy in the prediction of joint destruction in patients with rheumatoid arthritis of recent onset. Rheumatol Int 15, 155–158 (1995). https://doi.org/10.1007/BF00301773

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00301773

Key words

Navigation